Filing Flows › Elevance Health (ELV) › Q1 2025
Elevance Health (ELV) Q1 2025 earnings results (first quarter 2025)
10-Q filed Apr 22, 2025
Elevance Health (ELV) reported revenue of $48.9B for the first quarter 2025 (Q1 2025), +15% from a year earlier and +8% from the quarter before. Operating margin was 6.5%, net earnings $2.2B (4.5% of revenue).
Elevance Health, Q1 2025: revenue $48.9B (+15% year over year), operating margin 6.5%, net earnings $2.2B, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $48.9B | +8% | +15% |
| Operating profit | $3.2B | +371% | +5% |
| Net earnings | $2.2B | +429% | -3% |
| Operating cash flow | $1.0B | +44% | -49% |
| Free cash flow | $821M | +114% | -52% |
What changed
Revenue was $48.9B in Q1 2025, up 15% year over year and up 8% from the previous quarter.
Operating profit was $3.2B, a 6.5% margin (down 0.6 points year over year). Of the extra revenue versus a year earlier, 2% reached operating profit, below the 7% margin then. Total costs grew 16% against revenue growth of 15%. The fastest-growing cost line was Cost of revenue (+30%). Net earnings were $2.2B, down 3% year over year. The effective tax rate was 21.9%.
Operating cash flow was $1.0B (down 49% year over year), 47% of net earnings. Non-cash charges added back $0.37B of depreciation and amortization and $0.08B of share-based compensation. Working capital and other items used $1.6B. Capital expenditures of $0.20B left free cash flow of $0.82B.
Questions
What was Elevance Health's revenue in the first quarter 2025?
Elevance Health (ELV) reported revenue of $48.9B for the first quarter 2025 (Q1 2025), +15% from a year earlier and +8% from the quarter before.
Was Elevance Health profitable in the first quarter 2025?
Operating profit was $3.2B (6.5% of revenue) and net earnings $2.2B.
Source: Elevance Health 10-Q on SEC EDGAR.